{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-012025-04-012025-04-022025-04-022025-04-032025-04-032025-04-042025-04-042025-04-052025-04-052025-04-062025-04-062025-04-072025-04-07121091180403349296845483912102002001601601201208080404000
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-012025-04-012025-04-022025-04-022025-04-032025-04-032025-04-042025-04-042025-04-052025-04-052025-04-062025-04-062025-04-072025-04-072618192395633392165363348271492002001601601201208080404000
Download SVG
Download PNG
Download CSV

ubs lowers nCino price target amid cautious revenue growth outlook

UBS analyst Nik Cremo has lowered the price target for nCino Inc. shares from $43 to $30 while maintaining a Buy rating, following the company's fiscal Q4 2025 results that exceeded revenue estimates but provided a cautious fiscal 2026 outlook. The stock has dropped nearly 25% in the past week due to concerns over slower subscription revenue growth and execution challenges, despite a healthy gross profit margin and a strong customer base. Other analysts have also adjusted their price targets, reflecting mixed views on nCino's financial outlook and growth potential.

ubs raises liberty formula one price target amid strong revenue growth

UBS has raised its price target for Liberty Formula One shares from $85 to $93, maintaining a Neutral rating, citing strong revenue resilience and expected growth from new sponsorship deals. The company reported fourth-quarter revenues of $1.167 billion, falling short of Guggenheim's expectations, yet the firm remains optimistic, raising its price target to $94. Liberty Media appointed Derek Chang as the new President and CEO, effective February 1, 2025, to enhance its portfolio and support growth.

ubs maintains buy rating for johnson and johnson amid challenges and opportunities

UBS has reiterated its Buy rating for Johnson & Johnson, setting a target price of $180, despite challenges from talc lawsuits. Analysts are optimistic about the company's core business, highlighting a 14% increase in prescriptions for Tremfya and potential approvals for new treatments. RBC Capital Markets also maintains an "Outperform" rating, emphasizing growth prospects in oncology, while Moody's affirms the company's strong financial position amid ongoing litigation.

ubs raises marex group price target to 45 dollars maintaining buy rating

UBS analyst Alex Kramm has raised the price target for Marex Group PLC from $40 to $45, maintaining a Buy rating, citing strong first quarter 2025 results and a robust competitive position. The company reported revenues of approximately $456.8 million, surpassing estimates, and a diluted EPS of $0.90, exceeding forecasts. Despite a downgrade from HSBC, other analysts have increased their price targets, reflecting confidence in Marex's growth potential amid ongoing market uncertainties.

deutsche bank lowers xylem price target but maintains buy rating

Deutsche Bank has adjusted its price target for Xylem Inc. to $136 from $140 while maintaining a Buy rating. Xylem specializes in engineered equipment for water and wastewater industries, with net sales primarily from transportation and water treatment systems (40.3%), hydraulic equipment (25.2%), and measurement and control systems (23.5%). Geographically, 53.7% of sales come from the United States, followed by Western Europe (22.5%) and other regions.

Deutsche Bank lowers Veralto price target while maintaining hold rating

Deutsche Bank has adjusted its price target for Veralto Corporation to $104 from $107 while maintaining a hold rating. Veralto operates through two main product families: water quality and analysis solutions, which account for 60.5% of net sales, and manufactured products, making up 39.5%. Geographically, net sales are primarily from the United States (43.4%), followed by China (7.1%), Germany (5.1%), and other regions (44.4%).

ubs maintains buy rating and price target for lennar shares

UBS has reaffirmed its Buy rating and $164 price target for Lennar Corporation, which is currently trading at $110.60. The company, known for its localized production strategy, reported a strong financial health score and generated $35.4 billion in revenue over the past year, despite facing challenges in the housing market. Analysts have adjusted their forecasts following Lennar's recent earnings report, reflecting cautious optimism amid ongoing market pressures.

ubs raises cboe price target to 235 amid strong trading volumes

UBS has raised its price target for CBOE Holdings to $235 from $220 while maintaining a Neutral rating, following positive earnings revisions and strong performance in index options. The stock is currently trading at $209.37, close to its 52-week high, with a projected 12% year-over-year revenue growth for Q1 2025. Despite the optimistic outlook, UBS prefers CME Group for its better volume exposure and valuation.

deutsche bank lowers pentair price target while maintaining buy rating

Deutsche Bank has adjusted its price target for Pentair plc to $106 from $110 while maintaining a Buy rating. Pentair focuses on sustainable water solutions across three segments: Flow, Water Solutions, and Pool, offering a range of products for residential, commercial, industrial, and agricultural applications.

ubs maintains buy rating and price target for lennar shares

UBS has reiterated its Buy rating and $164 price target for Lennar Corporation, highlighting the company's effective "even-flow" production strategy that allows for local market adaptability. Despite trading near its 52-week low at $110.60, Lennar boasts strong financial health with a current ratio of 6.97 and a gross margin of 22.5%. Analysts have adjusted forecasts following a strong earnings report, reflecting cautious optimism amid a challenging housing market.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.